Nexsen (NXN) Short Interest
Nexsen (ASX:NXN) had 0.02% of shares reported as short positions as of 6 July 2026, representing 21,838 shares. Nexsen operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Nexsen
Short position
Nexsen (ASX:NXN) has 0.02% of its shares on issue reported as short positions as of 6 July 2026, or about 21,838 shares. NXN is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 34, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4NXN intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Latest NXN news
All news- Nexsen (ASX:NXN) Advances Point-of-Care Diagnostics Platform as StrepSure Regulatory Pathway Shapes Future Growth - Kalkine
googlenews
- Quarterly Report - Q4 FY26
asx
- Launch of Hong Kong facility & pipeline expansion
asx
- Nexsen (ASX:NXN) Ticks Higher: What's Sparking Interest in This Explorer? - Kalkine
googlenews
- Why Did Nexsen (ASX: NXN) Retreat Despite a 40% One-Year Gain? - Kalkine
googlenews
About
Company information is being updated. Check back soon.
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss NXN
Start a research thread or post the first pulse update